亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

Calycosin毛蕊異黃酮 ?20575-57-9

 
 
單價 面議對比
詢價 暫無
發(fā)貨 四川成都市付款后3天內(nèi)
庫存 1000g起訂1g
品牌 成都云希
CAS號 20575-57-9
過期 長期有效
更新 2021-08-07 11:00
 

成都云希化工有限公司

企業(yè)會員第6年
資料未認(rèn)證
保證金未繳納
詳細(xì)說明

Cat. No.: YS0221

CAS Number: 20575-57-9

M. F.: C16H12O5

M. W.: 284.26

Package: Brown vial
Storage: 2-8℃,Cool and Dry place, protected from light, keep package airproofed when not in use. Please store in 2-8℃ for long term storage



成都云希產(chǎn)品:
抗皺抗衰類:阿基瑞林,乙酰基八肽-3,芋螺肽,膠原肽,棕櫚酰五肽-3,五肽-18,六肽-10,脂肽,維洛斯肽,L-肌肽,基肽3000等
美白淡斑類:四肽-30,九肽-1,亮膚素,十肽-12,寡肽-68等
促進(jìn)毛發(fā)生長類:肉豆蔻酰五肽-17/睫毛肽,乙酰基四肽-3/促眉肽(Capixyl),生物素三肽-1(Procapil),銅肽等
抗敏抗炎類:棕櫚酰四肽-7,乙酰基六肽-49,棕櫚酰三肽-8等
眼部護(hù)理類:二肽-2,乙酰基四肽-5(眼絲氨肽),眼麗肽(Eyeliss)等
抗痘類:機(jī)體防御肽(Bodyfension),肉豆蔻酰六肽-23,LZ1,LL37等
屏障修復(fù)類:乙酰基七肽-4
增加/減少局部脂肪體積:乙酰六肽-38 (Adifyline);乙酰六肽-39(Silusyne);五肽-25等
以及玻色因及其他多種化妝品原料、復(fù)合肽類、寡肽類、重組蛋白類、多肽中間體、植物單體、藥物肽等。云希嚴(yán)格按照標(biāo)準(zhǔn)化生產(chǎn)和質(zhì)量管理,優(yōu)價提供各品種原料,及各類半成品(原液、凍干粉等)。

舉報收藏 0評論 0
更多>本企業(yè)其它產(chǎn)品
云希專注勝肽乙酰基六肽-49/DELISENS 乙酰基六肽-1 乙酰基四肽-2 三肽-10瓜氨酸/核心蛋白聚糖肽 Polypeptide-23 乙酰基六肽-7抗衰多肽 Sh-Decapeptide-7 Oligopeptide-21/寡肽21
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |